Pharmabiz

MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001

MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001: Shanghai Saturday, February 28, 2026, 18:00 Hrs [IST] MindRank, a cli ...
Pharmabiz

YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform

YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform: Taipei, Taiwan Saturday, February 28, 2026, 15:00 Hrs [IST] YD Bio Limited, a biotechnology c ...
Pharmabiz

ViiV Healthcare presents data for two investigational HIV treatment therapies with potential for twice-yearly dosing

ViiV Healthcare presents data for two investigational HIV treatment therapies with potential for twice-yearly dosing: London Saturday, February 28, 2026, 13:00 Hrs [IST] ViiV Heal ...
Pharmabiz

Intelligent Bio Solutions ships Intelligent Fingerprinting Drug Screening Readers with Syrma Johari MedTech

Intelligent Bio Solutions ships Intelligent Fingerprinting Drug Screening Readers with Syrma Johari MedTech: New York Saturday, February 28, 2026, 16:00 Hrs [IST] Intelligent Bio ...
Pharmabiz

CollPlant Biotechnologies’ photocurable dermal filler technology receives Korean Patent

CollPlant Biotechnologies’ photocurable dermal filler technology receives Korean Patent: Rehovot, Israel Saturday, February 28, 2026, 14:00 Hrs [IST] CollPlant Biotechnologies, ...
Pharmabiz

Core Solutions introduces DSP Assist mobile app for compliant IDD service delivery

Core Solutions introduces DSP Assist mobile app for compliant IDD service delivery: King of Prussia, Pennsylvania Saturday, February 28, 2026, 17:00 Hrs [IST] Core Solutions (Core ...
Pharmabiz

US FDA accepts Viatris’ sNDA of MR-141 to review for treatment of presbyopia

US FDA accepts Viatris’ sNDA of MR-141 to review for treatment of presbyopia: Pittsburgh Saturday, February 28, 2026, 12:00 Hrs [IST] Viatris Inc, US-headquartered global health ...